Clearstead Advisors, LLC Y M Abs Therapeutics, Inc. Transaction History
Clearstead Advisors, LLC
- $6.94 Billion
- Q2 2025
A detailed history of Clearstead Advisors, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 9 shares of YMAB stock, worth $77. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9Holding current value
$77% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding YMAB
# of Institutions
97Shares Held
26MCall Options Held
24KPut Options Held
0-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$36.5 Million0.89% of portfolio
-
Acorn Capital Advisors, LLC New York, NY3.42MShares$29.4 Million10.09% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$25.3 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$18.9 Million0.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$16.7 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $376M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...